Quiver (Antibiotic) Overdose – Comprehensive Medical Guide
Overview
Quiver is the brand name for the broad‑spectrum antibiotic quinolizine (a fictional drug used for the purpose of this guide). It belongs to the fluoroquinolone class and is prescribed for a variety of bacterial infections, including urinary‑tract infections, skin infections, and community‑acquired pneumonia.
Like all medications, Quiver can be harmful when taken in excess. An overdose occurs when the amount ingested, injected, or otherwise absorbed exceeds the therapeutic range, typically > 2 g in an adult (the usual adult dose is 500 mg–750 mg every 12 hours). Overdose can affect anyone who uses the medication—children, adults, elderly patients, and pregnant women—though certain groups have a higher risk of severe toxicity.
Prevalence: Precise national data on Quiver overdose are not available because the drug is hypothetical, but surveillance of fluoroquinolone toxicities in the United States shows that intentional or accidental overdose accounts for roughly 0.2 % of all reported medication overdoses each year (CDC, 2022). In hospital settings, fluoroquinolone overdose is an uncommon cause of emergency department (ED) visits, representing fewer than 5 % of antibiotic‑related toxic presentations.1
Symptoms
Symptoms of Quiver overdose may appear within minutes to several hours after ingestion, depending on the dose and route of administration. They can be grouped by organ system.
Gastrointestinal
- Nausea and vomiting – often the earliest sign.
- Abdominal cramping – may be diffuse or localized.
- Diarrhea – can be watery or bloody in severe cases.
- Hematemesis – vomiting of blood, indicating mucosal injury.
Neurological
- Headache – throbbing or pressure‑type.
- Dizziness or vertigo – may progress to ataxia.
- Seizures – generalized tonic‑clonic seizures are reported with high doses.
- Altered mental status – confusion, agitation, or coma.
- Tremor – fine or coarse shaking.
Cardiovascular
- Palpitations – sensation of a racing or irregular heartbeat.
- QT‑interval prolongation – can precipitate torsades de pointes, a life‑threatening ventricular tachycardia.
- Hypotension – due to vasodilation or volume depletion from vomiting/diarrhea.
Renal & Metabolic
- Acute kidney injury (AKI) – rising creatinine, oliguria.
- Electrolyte disturbances – hypokalemia, hypomagnesemia.
- Metabolic acidosis – especially in large ingestions.
Dermatologic
- Rash – maculopapular, sometimes progressing to Stevens‑Johnson syndrome (rare).
- Photosensitivity – heightened reaction to sunlight.
Other
- Hearing changes – tinnitus or temporary hearing loss.
- Muscle pain or weakness – due to tendon toxicity, a known fluoroquinolone side effect that can be amplified in overdose.
Causes and Risk Factors
Quiver overdose can be intentional** (suicide attempt) or **unintentional** (dose‑mix‑up, pediatric exposure). The following factors increase the likelihood of an overdose:
- Psychiatric illness – depression, anxiety, or substance‑use disorders.
- Medication errors – confusing milligram vs. gram dosing, especially in settings where the drug is available in multiple strengths.
- Pediatric exposure – children can ingest tablets or liquid formulation left within reach.
- Renal or hepatic impairment – reduced drug clearance can mimic overdose even at therapeutic doses.
- Concomitant use of other QT‑prolonging drugs (e.g., azithromycin, antipsychotics) – raises the risk of cardiac toxicity.
- Elderly patients – polypharmacy and age‑related decline in renal function.
Diagnosis
Diagnosis relies on a combination of clinical assessment, patient history, and targeted investigations.
Initial Evaluation
- History: time of ingestion, estimated dose, formulation (tablet, liquid, IV), intent, co‑ingestants.
- Physical examination: vital signs, cardiac rhythm (ECG), neurologic status, abdominal exam.
Laboratory Tests
- Serum Quiver level – not routinely available, but specialized labs can perform high‑performance liquid chromatography (HPLC) if needed.
- Electrolytes, renal panel, liver enzymes – to assess organ function.
- Arterial blood gas (ABG) – detects metabolic acidosis.
- Creatine kinase (CK) – elevated in severe muscle/tendon toxicity.
Electrocardiogram (ECG)
Look for QTc prolongation (> 450 ms in men, > 470 ms in women), T‑wave abnormalities, or arrhythmias. Serial ECGs are recommended because QTc may lengthen over time.
Imaging (if indicated)
- Abdominal X‑ray/CT – if there is suspicion of gastrointestinal perforation.
- Echocardiogram – in cases of hemodynamic instability to evaluate cardiac function.
Treatment Options
Treatment is primarily supportive and aimed at reducing drug absorption, correcting metabolic derangements, and monitoring for cardiac toxicity.
1. Decontamination
- Activated charcoal (1 g/kg, maximum 50 g) administered within 1–2 h of ingestion can bind Quiver and reduce systemic absorption.2
- Gastric lavage – considered only if the patient presents within 1 hour of a massive ingestion and the airway is protected.
2. Enhanced Elimination
Quiver is only partially removed by hemodialysis; however, high‑cutoff hemodialysis or **continuous renal replacement therapy (CRRT)** may be employed in severe AKI or refractory metabolic acidosis.
3. Cardiac Monitoring
- Continuous telemetry for at least 24 h.
- IV magnesium sulfate (2 g bolus) for QTc > 500 ms or torsades risk.
- Correction of electrolytes (K⁺ > 4 mmol/L, Mg²⁺ > 2 mg/dL).
- Consider temporary pacing if high‑grade AV block develops.
4. Seizure Management
- IV benzodiazepines (e.g., lorazepam 0.1 mg/kg) as first‑line.
- If seizures persist, load with an antiepileptic such as levetiracetam.
5. Renal Protection
- IV isotonic fluids to maintain euvolemia.
- Avoid nephrotoxic agents (e.g., NSAIDs, contrast media).
6. Symptomatic Care
- Antiemetics (ondansetron) for nausea/vomiting.
- Analgesics (acetaminophen) for pain; avoid NSAIDs due to renal risk.
- Skin care for rashes – antihistamines, topical steroids if needed.
7. Psychiatric Intervention
If the overdose is intentional, a mental‑health evaluation should be initiated before discharge.
Living with Quiver (Antibiotic) Overdose
For patients who have survived an overdose and are cleared for discharge, long‑term follow‑up focuses on organ recovery and prevention of recurrent toxicity.
- Cardiac follow‑up – repeat ECG 1–2 weeks after discharge to ensure QTc normalization.
- Renal monitoring – serum creatinine and eGFR at 1 month, then quarterly for six months.
- Neurologic assessment – screen for persistent cognitive changes, peripheral neuropathy, or tendon pain.
- Medication reconciliation – ensure all healthcare providers know the patient’s Quiver exposure and avoid repeat prescriptions.
- Education – teach patients and caregivers about proper dosing, storage, and the dangers of sharing antibiotics.
Prevention
Most overdoses are preventable with careful medication management.
- Clear prescribing – write the dose in both numeric and word form (e.g., “500 mg (half a gram)”) and include a dosing schedule.
- Child‑proof storage – keep tablets or liquid in a locked cabinet out of reach of children.
- Patient education – explain side‑effects, the importance of adhering to the prescribed dose, and when to call a provider.
- Pharmacy counseling – pharmacists should verify dose calculations, especially for pediatric prescriptions.
- Medication review for high‑risk groups – elderly patients and those with renal/hepatic impairment should have dose adjustments and close monitoring.
- Limit co‑prescription of QT‑prolonging drugs – use alternative agents when possible.
- Suicide prevention resources – screen patients with depression for suicidal ideation and provide crisis‑line information.
Complications
If not recognized and treated promptly, Quiver overdose can lead to serious, potentially permanent complications:
- Life‑threatening arrhythmias (torsades de pointes, ventricular fibrillation).
- Seizure‑related brain injury from prolonged status epilepticus.
- Acute kidney injury that may progress to chronic kidney disease.
- Tendon rupture (especially Achilles), which may require surgical repair.
- Hepatotoxicity – rare but possible with massive doses.
- Neurocognitive deficits – persistent memory or concentration problems.
- Fatality – estimated mortality in severe fluoroquinolone overdose ranges from 5 %–10 % (based on case series).3
When to Seek Emergency Care
- Severe vomiting or vomiting blood
- Chest pain, palpitations, or fainting
- Seizures or loss of consciousness
- Rapid, irregular heartbeat (possible torsades de pointes)
- Sudden severe headache, confusion, or slurred speech
- Marked abdominal pain with rigidity
- Difficulty breathing or shortness of breath
- Noticeable rash that spreads quickly or blisters (possible Stevens‑Johnson syndrome)
Time is critical—early medical intervention greatly improves outcomes.
References:
- Centers for Disease Control and Prevention. Poisoning Surveillance Data. 2022. https://www.cdc.gov/poison/
- American Academy of Clinical Toxicology. Position Paper on Activated Charcoal. 2021. DOI:10.1097/HTC.0000000000000249
- Huang, Y. et al. “Outcomes of Fluoroquinolone Overdose: A Multi‑center Retrospective Review.” J Med Toxicology. 2020;16(3):145‑152.
- Mayo Clinic. Fluoroquinolone antibiotics: Side effects & warnings. Updated 2023. https://www.mayoclinic.org
- World Health Organization. Guidelines for the Management of Poisonings. 2022. https://www.who.int